SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-19-001034
Filing Date
2019-12-16
Accepted
2019-12-16 16:16:00
Documents
1
Period of Report
2019-12-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 14951
  Complete submission text file 0000905148-19-001034.txt   16237
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 500 CRESCENT COURT SUITE 250 DALLAS TX 75201
Business Address
McGaughy R Kent Jr (Reporting) CIK: 0001402856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 191287298